High alanine aminotransaminase associated with daptomycin use in a premature infant

1Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 Pt 1):285-91. doi: 10.1542/peds.110.2.285. Stoll BJ Hansen N Fanaroff AA Wright LL Carlo WA Ehrenkranz RA et al Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network Pediatrics 2002 110 2 Pt 1 285 91 10.1542/peds.110.2.28512165580Open DOISearch in Google Scholar

2Critchley IA, Draghi DC, Sahm DF, Thornsberry C, Jones ME, Karlowsky JA. Activity of daptomycin against susceptible and multidrug-resistant gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001. J Antimicrob Chemother. 2003;51(3):639-49. doi: 10.1093/jac/dkg130. Critchley IA Draghi DC Sahm DF Thornsberry C Jones ME Karlowsky JA Activity of daptomycin against susceptible and multidrug-resistant gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001 J Antimicrob Chemother 2003 51 3 639 49 10.1093/jac/dkg13012615866Open DOISearch in Google Scholar

3Cubicin (daptomycin for injection) [package insert]. Lexington MCP. Cubicin (daptomycin for injection) [package insert] Lexington MCPSearch in Google Scholar

4Cohen-Wolkowiez M, Watt KM, Hornik CP, Benjamin DK Jr, Smith PB. Pharmacokinetics and tolerability of single-dose daptomycin in young infants. Pediatr Infect Dis J. 2012;31(9):935-7. doi: 10.1097/INF.0b013e31825d2fa2. Cohen-Wolkowiez M KM Watt CP Hornik DK Jr Benjamin PB Smith Pharmacokinetics and tolerability of single-dose daptomycin in young infants Pediatr Infect Dis J 2012 31 9 935 7 10.1097/INF.0b013e31825d2fa2342103822627869Open DOISearch in Google Scholar

5Abdel-Rahman SM, Chandorkar G, Akins RL, Bradley JS, Jacobs RF, Donovan J, et al. Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved gram-positive infections. Pediatr Infect Dis J. 2011;30(8):712-4. doi: 10.1097/INF.0b013e31820fc8e1. Abdel-Rahman SM Chandorkar G Akins RL Bradley JS Jacobs RF Donovan J et al Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved gram-positive infections Pediatr Infect Dis J 2011 30 8 712 4 10.1097/INF.0b013e31820fc8e121317681Open DOISearch in Google Scholar

6Sader HS, Farrell DJ, Flamm RK, Jones RN. Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8 years of a Worldwide Surveillance Programme (2005-2012). Int J Antimicrob Agents. 2014;43(5):465-9. doi: 10.1016/j.ijantimicag.2014.01.018. Sader HS Farrell DJ Flamm RK Jones RN Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8 years of a Worldwide Surveillance Programme (2005-2012) Int J Antimicrob Agents 2014 43 5 465 9 10.1016/j.ijantimicag.2014.01.01824636430Open DOISearch in Google Scholar

7Bradley JS, Benziger D, Bokesch P, Jacobs R. Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age. Pediatr Infect Dis J. 2014;33(9):936-9. doi: 10.1097/INF.0000000000000318. Bradley JS Benziger D Bokesch P Jacobs R Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age Pediatr Infect Dis J 2014 33 9 936 9 10.1097/INF.000000000000031825361023Open DOISearch in Google Scholar

8Cohen-Wolkowiez M, Smith PB, Benjamin DK Jr, Fowler VG Jr, Wade KC. Daptomycin use in infants: report of two cases with peak and trough drug concentrations. J Perinatol. 2008;28(3):2334. doi: 10.1038/sj.jp.7211898. Cohen-Wolkowiez M PB Smith DK Jr Benjamin VG Jr Fowler KC Wade Daptomycin use in infants: report of two cases with peak and trough drug concentrations J Perinatol 2008 28 3 2334 10.1038/sj.jp.7211898275214018309318Open DOISearch in Google Scholar

9Abdel-Rahman SM, Benziger DP, Jacobs RF, Jafri HS, Hong EF, Kearns GL. Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections. Pediatr Infect Dis J. 2008;27(4):330-4. doi: 10.1097/INF.0b013e318160edfc. Abdel-Rahman SM DP Benziger RF Jacobs HS Jafri EF Hong GL Kearns Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections Pediatr Infect Dis J 2008 27 4 330 4 10.1097/INF.0b013e318160edfc18316988Open DOISearch in Google Scholar

10Bohm N, Makowski C, Machado M, Davie A, Seabrook N, Wheless L, et al. Case report and cohort analysis of drug-induced liver injury associated with daptomycin. Antimicrob Agents Chemother. 2014;58(8):4902-3. doi: 10.1128/AAC.03157-14. Bohm N Makowski C Machado M Davie A Seabrook N Wheless L et al Case report and cohort analysis of drug-induced liver injury associated with daptomycin Antimicrob Agents Chemother 2014 58 8 4902 3 10.1128/AAC.03157-14413603024820087Open DOISearch in Google Scholar